Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Cinacalcet impurity 4 is a chemical impurity associated with the drug Cinacalcet, which acts as a calcium-sensing receptor agonist. This impurity is relevant for analytical and quality control studies in pharmaceutical development related to Cinacalcet. Its identification and characterization are crucial for ensuring the purity and safety of therapeutic formulations. -
Drug Intermediate
3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-propionic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a crucial building block in the development of various therapeutic agents, facilitating the formation of complex structures for drug discovery. Its applications extend to medicinal chemistry, where it aids in the preparation of bioactive molecules targeting diverse biological pathways. -
Drug Impurity
Quetiapine impurity 10 is a chemical impurity associated with Quetiapine, an atypical antipsychotic. This compound serves as an essential reference standard for the identification and quantification of impurities in pharmaceutical formulations. Its analysis is critical for ensuring the purity and safety of Quetiapine in clinical and research applications. -
Drug Impurity
Methotrexate impurity 5, also known as Methotrexate α-Methyl Ester, is a chemical impurity associated with Methotrexate. This compound may serve as a valuable reference standard for quality control and analytical applications in pharmaceutical research. It aids in the evaluation of the purity and stability of Methotrexate formulations, contributing to the understanding of drug behavior and effectiveness. -
Drug Impurity
Bupropion impurity 18 is a characterized impurity of the antidepressant Bupropion. This compound serves as an important reference standard for analytical methods and quality control in pharmaceutical research. Its presence can influence the pharmacokinetic and pharmacodynamic properties of the parent drug, making it critical for studies evaluating drug safety and efficacy. Bupropion impurity 18 is essential for ensuring the integrity of Bupropion formulations in regulatory assessments. -
Drug Impurity
Acetazolamide impurity 5 is a chemical impurity associated with the drug Acetazolamide, which acts as a carbonic anhydrase inhibitor. This compound is primarily utilized in pharmaceutical research to assess the purity of Acetazolamide formulations and to study its potential effects in drug development. Understanding such impurities is critical for evaluating drug safety, efficacy, and regulatory compliance. -
Drug Impurity
Itraconazole impurity 10, also known as trans-Itraconazole, is a drug impurity associated with the antifungal agent Itraconazole. This compound serves as a valuable reference standard for analytical applications, including pharmacokinetic studies and quality control testing. Its characterization aids in understanding the stability and degradation pathways of Itraconazole in pharmaceutical formulations. Researchers can utilize this impurity to ensure compliance with regulatory standards in drug development. -
Drug Impurity
Testosterone impurity 28 is a defined impurity associated with testosterone. It serves as an important reference standard for the analysis and quality control of testosterone formulations. This impurity can be utilized in various research applications, including pharmacokinetics and toxicology studies, to ensure the integrity and safety of testosterone-related products. -
Drug Impurity
Budesonide impurity 84, also known as Di-Norbudesonide (mixture of diastereomers), serves as a relevant drug impurity in the characterization of Budesonide. This compound is utilized in pharmaceutical research for the investigation of drug stability, efficacy, and safety profiles. Its analysis is crucial for the development and quality control of corticosteroid formulations, ensuring compliance with regulatory standards. -
Drug Impurity
Levofloxacin impurity 10 is a drug impurity associated with the antibiotic levofloxacin. It serves as a key reference standard for analytical testing and quality control in pharmaceutical formulations. This compound plays a critical role in the assessment of drug purity and stability, aiding researchers in ensuring compliance with regulatory standards during drug development processes. -
Drug Impurity
Salmeterol impurity 10 is a known impurity of the long-acting β2 adrenergic agonist Salmeterol. This compound serves as a reference standard for analytical methods and is crucial for the quality control of pharmaceutical formulations containing Salmeterol. Its characterization is essential for ensuring the purity and efficacy of respiratory medications, particularly in the treatment of asthma and chronic obstructive pulmonary disease (COPD). -
Drug Impurity
Trazodone Impurity 3 Hydrochloride is a known impurity of Trazodone Hydrochloride. This compound serves as a critical reference standard for the identification and quantification of impurities in pharmaceutical formulations. It is primarily utilized in quality control and analytical studies to ensure compliance with regulatory guidelines in drug manufacturing. -
Drug Impurity
Gabapentin acid impurity 3 is a chemical impurity associated with the synthesis of Gabapentin acid. This compound is primarily used for quality control and analytical purposes in the pharmaceutical industry. Its presence and quantification are critical for assessing the purity of Gabapentin acid in drug formulations. -
Drug Impurity
Levothyroxine impurity 3 is a known impurity associated with Levothyroxine, a synthetic thyroid hormone. This compound is essential for research focused on the characterization of drug impurities, stability studies, and quality control of pharmaceutical formulations. It aids in understanding the impact of impurities on the efficacy and safety of thyroid medications. -
Losartan Impurity
Losartan Impurity 15 is a chemical entity related to Losartan, specifically characterized by the presence of an azido group. This impurity serves as an important analytical reference for the characterization and quality assessment of Losartan synthesis. It is commonly utilized in pharmaceutical research to study the stability and degradation pathways of Losartan, as well as to ensure compliance with regulatory standards for drug purity. -
Drug Impurity
Afatinib impurity 58 is a chemical reagent that serves as an impurity associated with the drug Afatinib. This compound may be utilized in analytical chemistry for quality control and stability studies of Afatinib formulations. Its presence is critical for ensuring the purity and safety of pharmaceutical products during research and development. -
Drug Impurity
Tenofovir impurity 20 is a chemical impurity associated with Tenofovir, an antiretroviral medication utilized in the treatment and prevention of HIV. This impurity is relevant for quality control and regulatory compliance in pharmaceutical research and development. It aids in the assessment of Tenofovir's purity and can be used in stability studies to ensure the integrity of therapeutic formulations. -
Drug Impurity
Clobazam impurity 1 is a characterized impurity associated with the anxiolytic agent Clobazam. This compound is essential for analytical purposes in quality control and method development for Clobazam formulations. Its presence and quantification can aid in assessing the purity and safety of pharmaceutical products containing Clobazam. -
Drug Impurity
Beclometasone dipropionate impurity 10 is a chemical impurity associated with the corticosteroid Beclometasone dipropionate. This impurity is relevant for drug quality assessments and stability studies in pharmaceutical research. It plays a critical role in ensuring the safety, efficacy, and regulatory compliance of corticosteroid formulations. Researchers can utilize this compound in purity testing and characterization of Beclometasone dipropionate. -
Drug Impurity
Prednisolone Impurity 6 is an identified impurity of the corticosteroid prednisolone. This compound is essential for understanding the purity profiles and characterization of prednisolone in pharmaceutical applications. It aids researchers in assessing the potential impacts of impurities on drug efficacy and safety, supporting quality control and compliance in drug development processes. -
Drug Intermediate
D-Pyroaspartic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its unique structure allows it to participate in the formation of various bioactive compounds, making it instrumental in the development of novel therapeutic agents. This compound serves as a valuable building block in chemical research and drug discovery applications. -
Drug Impurity
Ibrutinib Impurity 1 is a chemical impurity associated with the pharmacological compound Ibrutinib, an inhibitor of Bruton's tyrosine kinase (BTK). This impurity is relevant for analytical chemistry and quality control applications in pharmaceutical development to ensure the purity and safety of Ibrutinib formulations. It serves as an important reference standard for assessing the effects and stability of drug formulations containing Ibrutinib. -
Drug Impurity
Famotidine impurity 3 is a known impurity associated with Famotidine. It serves as a critical analytical standard for assessing the purity and quality of Famotidine formulations. This compound is essential for regulatory compliance and quality control in pharmaceutical research and development, particularly in studies examining drug stability and degradation profiles. -
Drug Impurity
Telmisartan impurity 13 is a chemical impurity associated with the antihypertensive agent Telmisartan. This compound can be utilized in quality control measures and analytical studies for drug formulation, ensuring the purity and efficacy of Telmisartan in pharmacological applications. Its characterization is crucial for compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Tamsulosin impurity 18 is a known impurity of the selective alpha-1 adrenergic antagonist, Tamsulosin, primarily utilized in the treatment of benign prostatic hyperplasia. This impurity is essential for quality control and analytical studies in pharmaceutical development, aiding in the assessment of Tamsulosin's purity and stability. Researchers can employ Tamsulosin impurity 18 for method validation, impurity profiling, and ensuring compliance with regulatory standards. -
Drug Intermediate
N-Fmoc-ethylenediamine hydrobromide is a crucial reagent for organic synthesis, primarily serving as a protective group for amino functionalities. This compound enhances the efficiency and selectivity of peptide and amino compound synthesis in biochemical research. Its properties make it an essential building block in various chemical reactions, facilitating the preparation of complex molecular structures. -
Drug Impurity
Adapalene impurity 1 is a known impurity associated with the topical retinoid Adapalene, primarily utilized for its role in dermatological treatments. Its presence necessitates monitoring during pharmaceutical formulation development to ensure product quality and efficacy. This reagent is integral for analytical studies focused on the characterization and quantification of drug impurities in pharmaceutical research. -
Drug Impurity
Duloxetine impurity 7 is a characterized impurity related to the pharmaceutical agent Duloxetine, which acts as a selective serotonin and norepinephrine reuptake inhibitor (SSNRI). This impurity is relevant for analytical chemistry and quality control in the production of Duloxetine, supporting the evaluation of purity and compliance with regulatory standards. Its study can provide insights into the synthesis and metabolic pathways of Duloxetine, aiding in the development of safer and more effective therapeutics. -
Drug Impurity
Levofloxacin impurity 1, also known as Levofloxacin impurity G, is a known impurity related to the antibiotic Levofloxacin. This compound serves as a valuable reference standard for analytical testing and quality control in pharmaceutical research and development. Its characterization can assist in the assessment of the purity and stability of Levofloxacin and facilitate investigations into potential drug interactions and efficacy. -
Drug Impurity
Dehydro glycopyrrolate bromide is identified as an impurity associated with the synthesis of glycopyrrolate. As a chemical research reagent, it is primarily utilized for quality control and validation within pharmaceutical development. Analysis of this impurity aids in understanding the stability and purity of glycopyrrolate formulations, thereby supporting regulatory compliance and product safety assessments. -
Drug Impurity
Hydroxychloroquine impurity 3 is a known impurity associated with Hydroxychloroquine. This chemical entity is utilized primarily in analytical chemistry to assess the purity of Hydroxychloroquine formulations. Its presence may influence the pharmacological properties of the main compound and is important for quality control in pharmaceutical research and development. -
Drug Impurity
Quetiapine impurity 22 is a chemical impurity associated with the antipsychotic medication Quetiapine. This impurity can be utilized in pharmaceutical research to evaluate the purity and stability of Quetiapine formulations, as well as to study potential metabolic byproducts. Its presence may impact the efficacy and safety profile of the drug, making it relevant for quality control in drug development and regulatory compliance studies. -
Drug Impurity
Acebutolol impurity 4 is a chemical impurity associated with the antihypertensive agent Acebutolol. This compound is employed in pharmaceutical research to establish the purity and quality of Acebutolol formulations. Its identification and characterization are essential for regulatory compliance and to ensure the efficacy and safety of the final pharmaceutical product. -
Drug Impurity
Betamethasone dipropionate impurity 7 is identified as an impurity associated with Betamethasone dipropionate. Its characterization is essential for ensuring the purity and quality of pharmaceutical formulations containing Betamethasone dipropionate. This compound serves as a reference standard for analytical techniques such as HPLC and mass spectrometry, facilitating method development and validation in quality control laboratories. -
Drug Impurity
Afatinib impurity 31 is a defined impurity related to the tyrosine kinase inhibitor Afatinib, which primarily targets EGFR (epidermal growth factor receptor). This compound serves as a reference standard for quality control in the synthesis and formulation of Afatinib, facilitating the assessment of drug purity in research and development settings. Its characterization is essential for ensuring compliance with regulatory standards in pharmaceutical applications. -
Drug Impurity
Azilsartan impurity 19, also known as N-Ethyl azilsartan medoxomil, is a drug impurity associated with Azilsartan. This compound serves as a reference standard for analytical chemistry applications, particularly in the quality control and validation of Azilsartan formulations. Its presence and characterization are essential for ensuring the safety and efficacy of pharmaceutical products containing Azilsartan. -
Drug Impurity
Ethambutol impurity 2 is a known impurity associated with the antitubercular agent Ethambutol. This compound serves as a critical reference standard in the quality control of Ethambutol formulations, aiding in the assessment of drug purity and the identification of potential contaminants. Its presence can significantly influence pharmacokinetic and therapeutic profiles, making it valuable for analytical studies and regulatory compliance in pharmaceutical research. -
Drug Impurity
Bumetanide impurity 2 is a recognized impurity associated with the diuretic agent Bumetanide. This compound serves as a critical reference standard for the assessment of purity in pharmaceutical formulations. Its analysis is essential for ensuring the safety and efficacy of drug products containing Bumetanide. Researchers can utilize this impurity in method development and validation studies within quality control laboratories. -
Drug Impurity
Diclofenac impurity 2 is a drug impurity associated with the pharmaceutical compound Diclofenac. It is primarily utilized in the pharmaceutical research and development sectors to ensure the safety and efficacy of drug formulations. The identification and quantification of this impurity are critical for compliance with regulatory standards and for understanding the drug's overall pharmacological profile. -
Drug Impurity
Clopidogrel impurity 7 bromide is a recognized impurity associated with Clopidogrel bromide, serving as an important component in drug quality control. This compound is utilized in analytical chemistry and pharmaceutical development to assess the purity and stability of clopidogrel formulations. Its identification and characterization are crucial for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Lopinavir impurity 6 is a characterized impurity of the antiretroviral drug Lopinavir, targeting the inhibition of HIV-1 protease. Its presence may impact the pharmacological profile and safety of Lopinavir formulations. This impurity is essential for quality control and stability studies in pharmaceutical development and is relevant for analytical research in drug production and regulatory compliance. -
Camphor Impurity
Camphor sulfonic acid methyl ester is a derivative of camphor, serving as a known impurity in camphor-based compounds. This reagent is primarily used in analytical chemistry for the identification and quantification of camphor impurities in various applications. Its role is critical in ensuring the purity and quality of camphor-containing products in pharmaceutical and chemical research. -
Drug Impurity
Lopinavir impurity 4 is a chemical impurity associated with the antiretroviral drug Lopinavir. This compound may serve as a reference standard for analytical purposes, aiding in the assessment of drug purity and stability in pharmaceutical formulations. Its characterization is crucial for regulatory compliance and quality control within the pharmaceutical industry. -
Drug Impurity
Methylprednisolone impurity 4, also known as 20-Carboxymethylprednisolone, serves as a significant impurity in the synthesis of Methylprednisolone. This compound is crucial for quality control and analytical studies related to steroid medication formulations. Its identification and quantification aid in ensuring the purity and efficacy of pharmaceutical products in research and development settings. -
Drug Intermediate
Hepta-O-acetyl-α-D-lactosyl bromide is a brominated lactoside that serves as a valuable drug intermediate. This compound acts as a synthetic substrate for perfluoroalkyl-labeled lactose lipids, facilitating research in glycosylation processes and carbohydrate chemistry. It is useful in studies focused on the development of glycosylated drugs and bioconjugates. -
Drug Impurity
Paricalcitol impurity 1 is a synthetic impurity associated with Paricalcitol, a compound targeting vitamin D receptors. This impurity can be utilized in pharmaceutical research to assess purity and stability of Paricalcitol formulations. Analysis of such impurities is vital for ensuring the quality and efficacy of vitamin D analogs in therapeutic applications. -
Drug Impurity
Furosemide impurity 3 is a drug impurity associated with the pharmaceutical compound furosemide. This impurity may arise during the synthesis or degradation of furosemide and is important for quality control and analytical studies. Research applications include the characterization of chemical properties and the assessment of impurity levels in furosemide formulations. -
Drug Impurity
1α,25-Dihydroxyprevitamin D3 impurity 1 is an impurity associated with 1α,25-Dihydroxyprevitamin D3, a biologically active metabolite of vitamin D. This reagent is primarily utilized in the study of vitamin D signalling pathways and drug development processes. Its presence can be important for quality control and analytical purposes in pharmaceutical formulations. -
Drug Impurity
Dabigatran impurity 37 is a known impurity of the anticoagulant dabigatran, primarily associated with its synthesis and quality control. This compound is used in analytical research to assess the purity and stability of dabigatran formulations. It serves as a reference for identifying potential degradation products and ensuring the integrity of pharmaceutical preparations. -
Drug Impurity
Rosuvastatin impurity 30 is a chemical impurity associated with Rosuvastatin, a potent HMG-CoA reductase inhibitor. This impurity can serve as a reference standard for analytical and quality control purposes in pharmaceutical research. Its identification and quantification are essential for ensuring the purity and efficacy of Rosuvastatin formulations in compliance with regulatory standards.
